We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.6B
AUM Growth
+$69.6M
Cap. Flow
+$51.5M
Cap. Flow %
0.92%
Top 10 Hldgs %
21.06%
Holding
781
New
66
Increased
297
Reduced
239
Closed
62
Avg Time Held
5.3 quarters
Top 10 Avg Time Held
2.7 quarters
Top 20 Avg Time Held
3.1 quarters

Top Sells

Rank Stock Value
1
PII icon
Polaris
PII
+$36M
2
TROW icon
T. Rowe Price
TROW
+$31.5M
3
ELV icon
Elevance Health
ELV
+$27.8M
4
ITC
ITC HOLDINGS CORP
ITC
+$26.5M
5
AMAT icon
Applied Materials
AMAT
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 19.08%
2 Financials 18.2%
3 Consumer Discretionary 11.88%
4 Technology 11.08%
5 Industrials 10.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MHFI
51
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$37.6M 0.67%
374,104
+2,451
+0.7% +$256K
2013 Q4
6 quarters
ARMH icon
52
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$37.5M 0.67%
761,310
+10,023
+1% +$521K
2013 Q2
8 quarters
GILD icon
53
Gilead Sciences
GILD
$186B
$37.1M 0.66%
316,596
+20,090
+7% +$2.2M
2013 Q2
8 quarters
APAM icon
54
Artisan Partners
APAM
$2.3B
$36.7M 0.66%
789,482
-30,873
-4% -$1.41M
2013 Q2
8 quarters
LYB icon
55
LyondellBasell Industries
LYB
$19.2B
$36.1M 0.64%
348,575
+336,665
+2,827% +$33.9M
2013 Q2
8 quarters
AGN
56
DELISTED
Allergan plc
AGN
$36M 0.64%
118,708
+1,606
+1% +$479K
2013 Q2
8 quarters
CPAY icon
57
Corpay
CPAY
$26.2B
$35M 0.63%
224,374
-716
-0.3% -$112K
2013 Q2
8 quarters
CAH icon
58
Cardinal Health
CAH
$54.8B
$32.9M 0.59%
392,931
+4,414
+1% +$390K
2014 Q1
5 quarters
BMY icon
59
Bristol-Myers Squibb
BMY
$117B
$32.4M 0.58%
486,881
+10,961
+2% +$722K
2013 Q2
8 quarters
EW icon
60
Edwards Lifesciences
EW
$49.4B
$31.9M 0.57%
1,342,410
+15,738
+1% +$355K
2013 Q2
8 quarters
ETP
61
DELISTED
Energy Transfer Partners, L.P.
ETP
$31.2M 0.56%
819,926
-5,566
-0.7% -$227K
2013 Q2
8 quarters
IDXX icon
62
Idexx Laboratories
IDXX
$41.2B
$30.8M 0.55%
480,778
-1,992
-0.4% -$138K
2014 Q4
2 quarters
CF icon
63
CF Industries
CF
$17.4B
$29.4M 0.53%
457,555
-255,460
-36% -$15.6M
2013 Q2
8 quarters
CVS icon
64
CVS Health
CVS
$112B
$28.8M 0.51%
274,679
+2,871
+1% +$293K
2013 Q2
8 quarters
UPS icon
65
United Parcel Service
UPS
$80.7B
$27.1M 0.48%
279,859
-2,044
-0.7% -$203K
2013 Q2
8 quarters
NXPI icon
66
NXP Semiconductors
NXPI
$56.9B
$25.8M 0.46%
262,659
+13,725
+6% +$1.41M
2014 Q4
2 quarters
AX icon
67
Axos Financial
AX
$5.06B
$25M 0.45%
944,976
+320,184
+51% +$7.61M
2014 Q4
2 quarters
SHW icon
68
Sherwin-Williams
SHW
$77.8B
$24.5M 0.44%
267,237
+10,191
+4% +$966K
2014 Q4
2 quarters
AYI icon
69
Acuity Brands
AYI
$8.91B
$24.1M 0.43%
134,146
+5,002
+4% +$878K
2015 Q1
1 quarter
BIP icon
70
Brookfield Infrastructure Partners
BIP
$16.9B
$23.4M 0.42%
1,319,331
-8,724
-0.7% -$154K
2013 Q2
8 quarters
CBRE icon
71
CBRE Group
CBRE
$37.7B
$22.5M 0.4%
608,068
+7,379
+1% +$280K
2014 Q2
4 quarters
CTSH icon
72
Cognizant
CTSH
$26.8B
$22.3M 0.4%
364,902
-977
-0.3% -$61.3K
2013 Q2
8 quarters
NOW icon
73
ServiceNow
NOW
$145B
$21.6M 0.39%
1,455,445
+60,155
+4% +$928K
2015 Q1
1 quarter
POT
74
DELISTED
Potash Corp Of Saskatchewan
POT
$21.6M 0.39%
698,035
-82,999
-11% -$2.66M
2014 Q1
5 quarters
TRIP icon
75
TripAdvisor
TRIP
$1.02B
$20.6M 0.37%
236,200
-10,338
-4% -$841K
2013 Q4
6 quarters

Similar funds

Geneva Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, Geneva Advisors held 781 positions worth $5.6B, up 1.3% from $5.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneva Advisors's Q2 2015 filing shows 66 new, 297 increased, 239 reduced and 62 closed positions. Its largest new stake was LinkedIn Corporation: 75,249 shares worth $15.5M. The largest sale was Polaris, an estimated $36M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Geneva Advisors's largest Q2 2015 buy was LinkedIn Corporation: 75,249 shares worth $15.5M.
  • Geneva Advisors added most to TD Ameritrade Holding Corp in Q2 2015, an estimated $41.7M increase.
  • Geneva Advisors's biggest Q2 2015 reduction was Polaris, cutting an estimated $36M.
  • Geneva Advisors fully exited Applied Materials in Q2 2015, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 21% of its $5.6B portfolio in Q2 2015.
  • Geneva Advisors opened 66 new positions and closed 62 in Q2 2015.
  • Geneva Advisors's portfolio value rose 1.3% quarter-over-quarter to $5.6B.

Based on Geneva Advisors's 13F filing for Q2 2015, filed 3 Aug 2015.